ImmunoGen, Inc. (IMGN): Price and Financial Metrics

ImmunoGen, Inc. (IMGN): $3.68

0.21 (+6.05%)

POWR Rating

Component Grades













Add IMGN to Watchlist
Sign Up

Industry: Biotech



in industry


  • Value is the dimension where IMGN ranks best; there it ranks ahead of 59.03% of US stocks.
  • The strongest trend for IMGN is in Stability, which has been heading down over the past 179 days.
  • IMGN ranks lowest in Momentum; there it ranks in the 4th percentile.

IMGN Stock Summary

  • Of note is the ratio of ImmunoGen Inc's sales and general administrative expense to its total operating expenses; merely 9.45% of US stocks have a lower such ratio.
  • IMGN's price/sales ratio is 15.34; that's higher than the P/S ratio of 90.77% of US stocks.
  • As for revenue growth, note that IMGN's revenue has grown -47.2% over the past 12 months; that beats the revenue growth of only 3.45% of US companies in our set.
  • Stocks with similar financial metrics, market capitalization, and price volatility to ImmunoGen Inc are MGNX, ATHX, JNCE, CLLS, and LPTX.
  • IMGN's SEC filings can be seen here. And to visit ImmunoGen Inc's official web site, go to

IMGN Valuation Summary

  • In comparison to the median Healthcare stock, IMGN's price/earnings ratio is 160% lower, now standing at -21.9.
  • IMGN's price/earnings ratio has moved up 60.5 over the prior 243 months.
  • IMGN's EV/EBIT ratio has moved up 60 over the prior 243 months.

Below are key valuation metrics over time for IMGN.

Stock Date P/S P/B P/E EV/EBIT
IMGN 2021-08-31 8.9 17.8 -21.9 -18.0
IMGN 2021-08-30 8.7 17.4 -21.4 -17.5
IMGN 2021-08-27 9.0 17.9 -22.0 -18.1
IMGN 2021-08-26 8.5 17.0 -20.8 -16.9
IMGN 2021-08-25 8.3 16.6 -20.4 -16.5
IMGN 2021-08-24 8.2 16.3 -20.1 -16.2

IMGN Growth Metrics

    The 3 year cash and equivalents growth rate now stands at 47.83%.
  • Its 2 year price growth rate is now at -59.17%.
  • Its 5 year revenue growth rate is now at 33.39%.
IMGN's revenue has moved down $21,509,000 over the prior 15 months.

The table below shows IMGN's growth in key financial areas (numbers in millions of US dollars).

Date Revenue Operating Cash Flow Net Income to Common Stock
2021-12-31 69.856 -169.416 -139.303
2021-09-30 127.662 -115.007 -70.743
2021-06-30 136.641 -110.612 -55.778
2021-03-31 134.718 -94.926 -49.335
2020-12-31 132.299 -78.62 -44.372
2020-09-30 91.365 -119.712 -70.946

IMGN's Quality Factors

The “Quality” component of the POWR Ratings focuses on 31 different factors of a companies fundamentals and operational strength. Here are some key insights as we drill into the specifics of these quality attributes.
  • IMGN has a Quality Grade of C, ranking ahead of 34.67% of graded US stocks.
  • IMGN's asset turnover comes in at 0.393 -- ranking 121st of 682 Pharmaceutical Products stocks.
  • TARO, HTBX, and ENTA are the stocks whose asset turnover ratios are most correlated with IMGN.

The table below shows IMGN's key quality metrics over time.

Period Asset Turnover Gross Margin ROIC
2021-09-30 0.393 1 1.722
2021-06-30 0.437 1 1.612
2021-03-31 0.442 1 1.694
2020-12-31 0.452 1 2.339
2020-09-30 0.347 1 9.437
2020-06-30 0.327 1 10.967

IMGN Price Target

For more insight on analysts targets of IMGN, see our IMGN price target page. And for a list of of all stocks sorted by upside potential based on analyst target price, see our Top Price Target page.

Average Price Target $9.79 Average Broker Recommendation 1.55 (Moderate Buy)

IMGN Stock Price Chart Interactive Chart >

Price chart for IMGN

IMGN Price/Volume Stats

Current price $3.68 52-week high $7.77
Prev. close $3.47 52-week low $3.36
Day low $3.45 Volume 4,407,685
Day high $3.76 Avg. volume 3,592,031
50-day MA $4.64 Dividend yield N/A
200-day MA $5.61 Market Cap 811.57M

ImmunoGen, Inc. (IMGN) Company Bio

Immunogen develops targeted anticancer therapeutics. The Company's ADC technology uses tumor-targeting antibodies to deliver an ImmunoGen cell-killing agent specifically to cancer cells. The company was founded in 1981 and is based in Waltham, Massachusetts.

IMGN Latest News Stream

Event/Time News Detail
Loading, please wait...

IMGN Latest Social Stream

Loading social stream, please wait...

View Full IMGN Social Stream

Latest IMGN News From Around the Web

Below are the latest news stories about ImmunoGen Inc that investors may wish to consider to help them evaluate IMGN as an investment opportunity.

ImmunoGen (IMGN) Reports Q4 Loss, Tops Revenue Estimates

ImmunoGen (IMGN) delivered earnings and revenue surprises of 5.56% and 6.96%, respectively, for the quarter ended December 2021. Do the numbers hold clues to what lies ahead for the stock?

Yahoo | February 25, 2022

ImmunoGen Reports Recent Progress and 2021 Financial Results

WALTHAM, Mass., February 25, 2022--ImmunoGen Reports Recent Progress and 2021 Financial Results

Yahoo | February 25, 2022

ImmunoGen Announces Webcast of Panel Discussion at Upcoming Cowen 42nd Annual Health Care Conference

WALTHAM, Mass., February 23, 2022--ImmunoGen Announces Webcast of Panel Discussion at Upcoming Cowen 42nd Annual Health Care Conference

Yahoo | February 23, 2022

ImmunoGen (IMGN) Up on Licensing Deal With Lilly Worth $1.7 B

ImmunoGen (IMGN) inks a licensing agreement with Eli Lilly, granting the latter rights to develop and commercialize ADCs directed toward targets selected by Lilly. Stock up.

Yahoo | February 16, 2022

Biotech Stock Roundup: BDSI Surges on Merger Deal, SGEN Down on Outlook & More

Merger updates from BioDelivery (BDSI) and Seagen (SGEN) earnings results are among a few key highlights from the biotech sector during the past week.

Yahoo | February 16, 2022

Read More 'IMGN' Stories Here

IMGN Price Returns

1-mo -24.44%
3-mo -32.97%
6-mo -23.49%
1-year -39.27%
3-year 84.92%
5-year -22.03%
YTD -50.40%
2021 15.04%
2020 26.35%
2019 6.35%
2018 -25.12%
2017 214.22%

Continue Researching IMGN

Want to see what other sources are saying about ImmunoGen Inc's financials and stock price? Try the links below:

ImmunoGen Inc (IMGN) Stock Price | Nasdaq
ImmunoGen Inc (IMGN) Stock Quote, History and News - Yahoo Finance
ImmunoGen Inc (IMGN) Stock Price and Basic Information | MarketWatch

Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from!

Page generated in 1.1489 seconds.